Logo image of NEWR

New Relic Inc (NEWR) Stock Fundamental Analysis

NYSE:NEWR - US64829B1008 - Common Stock

86.99 USD
+0.02 (+0.02%)
Last: 11/7/2023, 8:12:48 PM
87 USD
+0.01 (+0.01%)
After Hours: 11/7/2023, 8:12:48 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to NEWR. NEWR was compared to 280 industry peers in the Software industry. While NEWR seems to be doing ok healthwise, there are quite some concerns on its profitability. NEWR is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

NEWR had positive earnings in the past year.
NEWR had a positive operating cash flow in the past year.
In the past 5 years NEWR always reported negative net income.
In the past 5 years NEWR always reported a positive cash flow from operatings.
NEWR Yearly Net Income VS EBIT VS OCF VS FCFNEWR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

NEWR has a Return On Assets (-16.14%) which is comparable to the rest of the industry.
NEWR has a Return On Equity (-37.27%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -16.14%
ROE -37.27%
ROIC N/A
ROA(3y)-14.67%
ROA(5y)-10.97%
ROE(3y)-59.02%
ROE(5y)-42.3%
ROIC(3y)N/A
ROIC(5y)N/A
NEWR Yearly ROA, ROE, ROICNEWR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

NEWR's Gross Margin of 76.88% is fine compared to the rest of the industry. NEWR outperforms 74.19% of its industry peers.
In the last couple of years the Gross Margin of NEWR has declined.
The Profit Margin and Operating Margin are not available for NEWR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.86%
GM growth 5Y-2.22%
NEWR Yearly Profit, Operating, Gross MarginsNEWR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 80

More info and screens

6

2. Health

2.1 Basic Checks

NEWR does not have a ROIC to compare to the WACC, probably because it is not profitable.
NEWR has more shares outstanding than it did 1 year ago.
NEWR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NEWR has a worse debt to assets ratio.
NEWR Yearly Shares OutstandingNEWR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
NEWR Yearly Total Debt VS Total AssetsNEWR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

2.2 Solvency

An Altman-Z score of 6.66 indicates that NEWR is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.66, NEWR is in the better half of the industry, outperforming 79.93% of the companies in the same industry.
NEWR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.66
ROIC/WACCN/A
WACC10.72%
NEWR Yearly LT Debt VS Equity VS FCFNEWR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.58 indicates that NEWR should not have too much problems paying its short term obligations.
The Current ratio of NEWR (1.58) is comparable to the rest of the industry.
A Quick Ratio of 1.58 indicates that NEWR should not have too much problems paying its short term obligations.
NEWR has a Quick ratio (1.58) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
NEWR Yearly Current Assets VS Current LiabilitesNEWR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 405.45% over the past year.
NEWR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.59% yearly.
NEWR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.48%.
The Revenue has been growing by 21.12% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)405.45%
EPS 3Y-2.59%
EPS 5YN/A
EPS Q2Q%292.31%
Revenue 1Y (TTM)13.48%
Revenue growth 3Y15.58%
Revenue growth 5Y21.12%
Sales Q2Q%6.98%

3.2 Future

The Earnings Per Share is expected to grow by 42.30% on average over the next years. This is a very strong growth
Based on estimates for the next years, NEWR will show a quite strong growth in Revenue. The Revenue will grow by 14.84% on average per year.
EPS Next Y186.08%
EPS Next 2Y85.65%
EPS Next 3Y56.67%
EPS Next 5Y42.3%
Revenue Next Year11.06%
Revenue Next 2Y12.49%
Revenue Next 3Y15.41%
Revenue Next 5Y14.84%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
NEWR Yearly Revenue VS EstimatesNEWR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
NEWR Yearly EPS VS EstimatesNEWR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 51.78, NEWR can be considered very expensive at the moment.
NEWR's Price/Earnings ratio is a bit cheaper when compared to the industry. NEWR is cheaper than 66.31% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.84, NEWR is valued quite expensively.
NEWR is valuated quite expensively with a Price/Forward Earnings ratio of 41.38.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NEWR indicates a somewhat cheap valuation: NEWR is cheaper than 63.80% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.48. NEWR is valued rather expensively when compared to this.
Industry RankSector Rank
PE 51.78
Fwd PE 41.38
NEWR Price Earnings VS Forward Price EarningsNEWR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

NEWR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 80.66
EV/EBITDA N/A
NEWR Per share dataNEWR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NEWR's earnings are expected to grow with 56.67% in the coming years.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y85.65%
EPS Next 3Y56.67%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NEWR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

New Relic Inc

NYSE:NEWR (11/7/2023, 8:12:48 PM)

After market: 87 +0.01 (+0.01%)

86.99

+0.02 (+0.02%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-27 2023-10-27/bmo
Earnings (Next)02-05 2024-02-05/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners5.84%
Ins Owner Change0%
Market Cap6.18B
Analysts68.18
Price Target88.03 (1.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.94%
Min EPS beat(2)26.69%
Max EPS beat(2)35.2%
EPS beat(4)4
Avg EPS beat(4)64.29%
Min EPS beat(4)26.69%
Max EPS beat(4)107.31%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.83%
Min Revenue beat(2)-5.11%
Max Revenue beat(2)-0.54%
Revenue beat(4)1
Avg Revenue beat(4)-1.51%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)1.01%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.61%
EPS NQ rev (1m)1.98%
EPS NQ rev (3m)0.86%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.01%
Revenue NQ rev (1m)-1.56%
Revenue NQ rev (3m)-1.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 51.78
Fwd PE 41.38
P/S 6.38
P/FCF 80.66
P/OCF 65.45
P/B 15.95
P/tB 29.92
EV/EBITDA N/A
EPS(TTM)1.68
EY1.93%
EPS(NY)2.1
Fwd EY2.42%
FCF(TTM)1.08
FCFY1.24%
OCF(TTM)1.33
OCFY1.53%
SpS13.62
BVpS5.46
TBVpS2.91
PEG (NY)0.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.14%
ROE -37.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.88%
FCFM 7.92%
ROA(3y)-14.67%
ROA(5y)-10.97%
ROE(3y)-59.02%
ROE(5y)-42.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.86%
GM growth 5Y-2.22%
F-Score7
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 42.97%
Cap/Sales 1.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 6.66
F-Score7
WACC10.72%
ROIC/WACCN/A
Cap/Depr(3y)29.68%
Cap/Depr(5y)52.98%
Cap/Sales(3y)3.11%
Cap/Sales(5y)6.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)405.45%
EPS 3Y-2.59%
EPS 5YN/A
EPS Q2Q%292.31%
EPS Next Y186.08%
EPS Next 2Y85.65%
EPS Next 3Y56.67%
EPS Next 5Y42.3%
Revenue 1Y (TTM)13.48%
Revenue growth 3Y15.58%
Revenue growth 5Y21.12%
Sales Q2Q%6.98%
Revenue Next Year11.06%
Revenue Next 2Y12.49%
Revenue Next 3Y15.41%
Revenue Next 5Y14.84%
EBIT growth 1Y45.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year861.55%
EBIT Next 3Y144.5%
EBIT Next 5YN/A
FCF growth 1Y384.71%
FCF growth 3Y5.83%
FCF growth 5Y28.88%
OCF growth 1Y1870.61%
OCF growth 3Y-16.81%
OCF growth 5Y8.54%